Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Azvudine versus Paxlovid in COVID-19: A systematic review and meta-analysis.
Amani B, Amani B. Amani B, et al. Rev Med Virol. 2024 Jul;34(4):e2551. doi: 10.1002/rmv.2551. Rev Med Virol. 2024. PMID: 38849982 Review.
This systematic review and meta-analysis aimed to compare the effectiveness and safety of azvudine versus nirmatrelvir/ritonavir (Paxlovid) in treating coronavirus disease 2019 (COVID-19). ...However, a significant difference was observed between the two groups in terms of …
This systematic review and meta-analysis aimed to compare the effectiveness and safety of azvudine versus nirmatrelvir/ritonavir (Pax …
Effectiveness of azvudine in reducing mortality of COVID-19 patients: a systematic review and meta-analysis.
Wang Y, Xie H, Wang L, Fan J, Zhang Y, Pan S, Zhou W, Chen Q, Liu X, Wu A, Zhang H, Wang J, Tian X. Wang Y, et al. Virol J. 2024 Feb 23;21(1):46. doi: 10.1186/s12985-024-02316-y. Virol J. 2024. PMID: 38395970 Free PMC article. Review.
BACKGROUND: Azvudine has been approved for the treatment of coronavirus disease 2019 (COVID-19) patients in China, and this meta-analysis aims to illustrate the safety of azvudine and its effectiveness in reducing mortality. ...The incidence of adverse events was si …
BACKGROUND: Azvudine has been approved for the treatment of coronavirus disease 2019 (COVID-19) patients in China, and this meta-anal …
Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis.
Amani B, Amani B. Amani B, et al. PLoS One. 2024 Jun 13;19(6):e0298772. doi: 10.1371/journal.pone.0298772. eCollection 2024. PLoS One. 2024. PMID: 38870134 Free PMC article.
OBJECTIVE: The aim of this study was to assess the effectiveness and safety of azvudine in treating coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). ...CONCLUSIONS: The antiviral effectiveness of azvudine ag …
OBJECTIVE: The aim of this study was to assess the effectiveness and safety of azvudine in treating coronavirus disease 2019 (COVID-1 …
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis.
Zheng B, Zhao Q, Yang W, Feng P, Xin C, Ying Y, Yang B, Han B, Zhu J, Zhang M, Li G. Zheng B, et al. Int J Antimicrob Agents. 2024 Mar;63(3):107096. doi: 10.1016/j.ijantimicag.2024.107096. Epub 2024 Jan 18. Int J Antimicrob Agents. 2024. PMID: 38244811 Free article. Review.
CONCLUSIONS: A thorough evaluation of effectiveness, applicable to both mild-to-moderate and unstratified populations, highlights the specific advantages of proxalutamide, nirmatrelvir/ritonavir, triazavirin, azvudine, molnupiravir, and VV116 in combating COVID-19. Additio …
CONCLUSIONS: A thorough evaluation of effectiveness, applicable to both mild-to-moderate and unstratified populations, highlights the specif …
Efficacy and Safety of Azvudine in Patients With COVID-19 in China: A Meta-Analysis of Observational Studies.
Dong T, Zhang W, Wu T, Ge Y, Yang Q, Xu J, Liu Y. Dong T, et al. Clin Respir J. 2024 Jul;18(7):e13798. doi: 10.1111/crj.13798. Clin Respir J. 2024. PMID: 38994643 Free PMC article.
BACKGROUND: Azvudine (FNC) is a novel small molecule antiviral drug for treating COVID-19 that is available only on the Chinese market. ...
BACKGROUND: Azvudine (FNC) is a novel small molecule antiviral drug for treating COVID-19 that is available only on the Chinese marke …
Evaluation of oral small molecule drugs for the treatment of COVID-19 patients: a systematic review and network meta-analysis.
Chen Z, Tian F. Chen Z, et al. Ann Med. 2023;55(2):2274511. doi: 10.1080/07853890.2023.2274511. Epub 2023 Nov 15. Ann Med. 2023. PMID: 37967171 Free PMC article.
A total of nine RCTs were included, including 30,970 COVID-19 patients comparing five treatments (azvudine, molnupiravir, paxlovid, VV116, and placebo). The Cochrane risk of bias tool for randomized trials (RoB) was used to assess the bias risk of the included studies. ...
A total of nine RCTs were included, including 30,970 COVID-19 patients comparing five treatments (azvudine, molnupiravir, paxlovid, V …